EP2081550

RELIANT PHARMACEUTICALS
Application Number
EP07752721A
Filing Date
Mar 9, 2007
Status
Patent Maintained As Amended
Apr 23, 2021
Grant Date
May 26, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2081550B2 was granted to Reliant Pharmaceuticals on May 26, 2021 following the initial filing on Mar 9, 2007 under the application number EP07752721A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHMEL & BETTENHAUSENJan 17, 2019ADMISSIBLE
FH SERVICESJan 17, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents